logo

For the Inventor, By the Inventor

New York, NY, United States of America

Enzo Biochem, Inc.


USPTO Granted Patents = 81

% Expired Patents = 8.6



Trademarks = 17

Forward Citations = 2,087

Loading Chart...
Loading Chart...

65 inventors (with patents filed for the assignee):

goldMedal Elazar S Rabbani (37 out of 122 patents)

silverMedal James J Donegan (31 out of 84 patents)

bronzeMedal Jannis G Stavrianopoulos (28 out of 95 patents)

4.  Jack Coleman (16 out of 63 patents)

5.  Praveen Pande (11 out of 44 patents)

6.  Xiaofeng Li (8 out of 17 patents)

7.  Dakai Liu (8 out of 28 patents)

8.  Joshua Rabbani (7 out of 14 patents)

9.  Zaiguo Li (7 out of 18 patents)

10.  Dean L Engelhardt (7 out of 18 patents)

11.  Natarajan Raju (6 out of 27 patents)

12.  Wayne Forrest Patton (6 out of 41 patents)

13.  Gerard Nuovo (4 out of 5 patents)

14.  Virginia Nivar (4 out of 4 patents)

15.  Richard Jin (3 out of 10 patents)


Core Competencies:
Nucleic Acid Detection
Immunomodulatory Compositions
Viral Diseases
Sphingosine Pathway
Wnt Pathway
Pharmaceutical Compositions
DNA Labeling
Hybridization Assays
Bone Formation
Fluorescent Dyes
Quantitative Detection
Analytical Processes

81 patents:

1. 12442031 - DNA labeling compositions and methods for comparative genomic hybridization (2025-10-14),
2. 12122921 - Fluorescence quencher polymer conjugates and uses thereof (2024-10-22),
3. 12061198 - Diagnosis and treatment of viral diseases (2024-08-13),
4. 11938167 - Pharmaceutical compositions and methods targeting Wnt pathway proteins (2024-03-26),
5. 11931344 - Sphingosine pathway modulating compounds for the treatment of coronavirus infection (2024-03-19),
6. 11865105 - Sphingosine pathway modulating compounds for the treatment of cancers (2024-01-09),
7. 11723895 - Sphingosine pathway modulating compounds for the treatment of coronavirus infection (2023-08-15),
8. 11667703 - Sulfonated sclerostin, antibodies, epitopes and methods for identification and use therefor (2023-06-06),
9. 11639382 - Antibodies specific for sulfation sites of Wnt pathway proteins (2023-05-02),
10. 11554111 - Sphingosine pathway modulating compounds for the treatment of coronavirus infection (2023-01-17),
11. 11173195 - Immunomodulatory pharmaceutical compositions including a synthetic peptide and transforming growth factor beta (2021-11-16),
12. 11167011 - Methods for treating bone loss using sclerostin peptides (2021-11-09),
13. 11066694 - Affinity tag nucleic acid and protein compositions, and processes for using same (2021-07-20),
14. 10899827 - Antibodies specific for sulfation sites of sclerostin (2021-01-26),
15. 10881643 - Sphingosine pathway modulating compounds for the treatment of cancers (2021-01-05),
Enzo Biochem, Inc. is a leading life sciences and biotechnology company that develops, manufactures, and commercializes innovative diagnostic and research products to improve healthcare and advance scientific discovery. With a focus on molecular biology, immunology, and pharmacology, Enzo Biochem provides a wide range of products and services for use in clinical laboratories, academic research institutions, and pharmaceutical companies worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Enzo Biochem, Inc.
81 Patents

#122 in New York, NY

#273 in New York

#4,569 in US

#9,334 in the World

New York, NY (US)
New York, NY, United States of America

Enzo Biochem, Inc.

Forward Citations = 2,087

65 inventors:

goldMedal Elazar S Rabbani (37 out of 122 patents)

silverMedal James J Donegan (31 out of 84 patents)

bronzeMedal Jannis G Stavrianopoulos (28 out of 95 patents)

4.  Jack Coleman (16 out of 63 patents)

5.  Praveen Pande (11 out of 44 patents)

Please report any incorrect information to [email protected]
Loading…